前列腺癌
基因组学
癌症
计算生物学
生物
基因组
大规模并行测序
基因组不稳定性
种系突变
生殖系
生物信息学
医学
遗传学
突变
基因
作者
Michael Fraser,Alexandre Rouette
标识
DOI:10.1007/978-3-030-32656-2_5
摘要
Over the last decade, advancements in massively-parallel DNA sequencing and computational biology have allowed for unprecedented insights into the fundamental mutational processes that underlie virtually every major cancer type. Two major cancer genomics consortia-The Cancer Genome Atlas (TCGA) and the International Cancer Genome Consortium (ICGC)-have produced rich databases of mutational, pathological, and clinical data that can be mined through web-based portals, allowing for correlative studies and testing of novel hypotheses on well-powered patient cohorts.In this chapter, we will review the impact of these technological developments on the understanding of molecular subtypes that promote prostate cancer initiation, progression, metastasis, and clinical aggression. In particular, we will focus on molecular subtypes that define clinically-relevant patient cohorts and assess how a better understanding of how these subtypes-in both somatic and germline genomes-may influence the clinical course for individual men diagnosed with prostate cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI